Drug Recall


HPS Pharmacies wish to advise that Sanofi-Aventis Australia, in consultation with the Therapeutic Goods Administration (TGA), have given notice of a drug recall of:

Stemetil® Tablets
Prochlorperazine maleate 5mg
ARTG 27564

The only affected batch is 16N0060 with an expiry date of June 2018.

This recall has been initiated as some packs may be missing a blister sheet leading to supply of a reduced quantity of tablets. There are no quality, safety, or efficacy issues with the affected batch.

Please inspect your stocks and quarantine all products from the batch stated above for return to your supplier for a refund.

If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect your stock and quarantine all products from the batch stated above for return to the supplier for a refund. Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your clinicians if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Sanofi-Aventis on 1800 152 416.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates